top of page
  • Facebook
  • White Twitter Icon
  • Soundcloud
  • White Instagram Icon
  • LinkedIn
  • TikTok

Clinical Endocannabinoid Deficiency

Updated: Jul 10, 2022

In 2004, about 12 years following the discovery of the endocannabinoid system (ECS), a theory regarding the existence of an endocannabinoid deficiency syndrome was published in a research paper entitled "Clinical Endocannabinoid Deficiency (CECD): Can This Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome, and Other Treatment-Resistant Conditions?"

Want to read more?

Subscribe to curtarobbins.wixsite.com to keep reading this exclusive post.

 
 
 

Higher Learning LV

There are many ways to learn from us, including 👇🏽

Teaching the Commerce + Chemistry of Cannabis™

Did You Know?

The cannabis genome produces 100+ cannabinoids, 150+ terpenes, and 20 flavonoids.

These phytomolecules interact with the human endocannabinoid system (ECS) to produce wellness.

But it gets complex. Biphasic response curves, biosynthetic pathways, and acidic precursors all commingle. Subscribe to learn how. 

Copyright © 2023 Higher Learning LV. All Rights Reserved. Unauthorized reuse strictly prohibited.

bottom of page